Pharma Reviews: Indian dose sites untapped M&A opportunity for foreign CMOs: GlobalData

Only six US, five UK, and three German CMOs own solid dose manufacturing sites in India.” Bradbury continues, “While the Indian pharma industry is ...
Read more: Indian dose sites untapped M&A opportunity for foreign CMOs: GlobalData